The Net Interest Income (NII) of the company for the quarter ending March 2025 was ₹365.3 crore, a 6.3% YoY increase ...

The approval includes multiple strengths: 15mg, 30mg, 45mg, 60mg, and 90mg, allowing for flexible dosing options.

Phytonadione, is used to treat blood clotting disorders by facilitating the proper synthesis of clotting factors II, VII, IX, ...

Once again, the decision to cut repo rates by 25 bps in April 2025 meeting was unanimous with all the 6 members of the MPC ...

The firm reported an EBITDA of ₹163.4 crore for the March 2025 quarter, falling 15.90% compared to ₹194.3 crore a year ago.

The table captures new business premium (NBP) growth of life insurers for March 2025 and the 12 months of FY25. Data Source: ...

Samhi Hotels Ltd. has made a strategic joint venture with Singapore sovereign wealth fund GIC. In the deal, GIC will invest ...

Total quarter revenue stood at ₹1,018 crore, an 11% YoY growth over ₹916.9 crore in the same quarter of the last fiscal.

The company saw a 9.7% y-o-y growth in its annual operating revenue, which increased to ₹1,308.04 crore in FY25 from ...

Net profit for the quarter jumped to ₹345 crore, a significant increase from ₹216 crore in the corresponding quarter last year.

However, Dalmia Bharat’s Q4 revenue from operations slipped 5% on a year-on-year basis to ₹4,091 Crore as compared to ₹4,154 ...

The fund to invest predominantly in Reverse repo, Triparty repo on Government securities or treasury bills and/or other ...